-
AstraZeneca: Clinical studies have shown that targeted anti-cancer drug Teresa can prolong progression free survival by more than 3 years
On June 2nd local time, AstraZeneca announced that positive results from the LAURA Phase III trial showed that Teresa (ositinib) showed statistically significant and highly clinically significant imp ... -
Millions of anti-cancer drugs are new! Legendary Biology's entry into the domestic market and attention paid to pricing. Can CAR-T therapy break through the four Warring States Talks Industry Observation
The "Million Dollar Anti Cancer Drug" is New! Legendary Biology's Entry into the Domestic Market and Pricing Attention. Can CAR-T Therapy Break the Four Warring States Talks? This year's H1 global sa ...